Purchase Order HHSN272201200019P
Award Date 10/11/11
Potential Completion Date 11/10/11
Potential Value $3.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID HHSN272201200181P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services (HHS). The $3,528.90 Firm Fixed Price contract was awarded to Bio Basic Canada Inc. on January 25, 2012 for the delivery of 1,200 units of synthetic genes related to the nucleoprotein of the Human Metapneumovirus (HMPV) at a unit price of $0.30, for a total of $360.00. The contract has an ultimate completion...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
- <p>This $23,991.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Protein Biosolutions Inc. on May 8, 2014. The contract is for AMBIS # 1678920 SEQUENCING services, with a period of performance ending on June 20, 2014. The contract was not set aside for any specific business type.</p>
- This federal contract award, with the ID HHSN272201200589P, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bio-Synthesis, Inc. (doing business as Dnaexam), a for-profit, Hispanic American-owned manufacturer. The contract, with a firm fixed price of $5,565.00, is for the delivery of drugs and biologicals. The contract does not have a set-aside designation and was awarded on July 18, 2012, with a...
- <p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Glycobiotech GMBH, a for-profit organization, for the delivery of BIOLOGICALS/ANTIBODIES. The contract has a ceiling value of $9,806.58 and an ultimate completion date of November 27, 2015. The contract was awarded on November 13, 2015 and does not have a set-aside designation.</p>
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Creative Dynamics, Inc. (DBA Creative Biolabs) for the acquisition of recombinant human anti-influenza A virus (IAV) antibody in a 5mg quantity. The contract has a ceiling value of $7,960.00 and was awarded on October 31, 2017, with a planned completion date of January 31, 2018. This contract does not...
- The federal contract award HHSN272201400119P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the prime contractor A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $30,264.00 firm-fixed-price purchase order is for the production of 1 mg of precision antibodies. This contract is not associated with a set-aside program. A&G Pharmaceutical, Inc. is a for-profit manufacturer of goods that...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients, to provide 1 gram of RON2 acetate salt peptide. The contract has a potential value of $45,750.00 and a completion date of January 18, 2019. The procurement was a sole-source award based on Bachem's status...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide protein antigen production for coronavirus vaccine antigens in support of COVID-19 research. The $139,989.48 contract has a completion date of September 23, 2022. Genscript has previously received federal awards from agencies such as the USDA to...